McLeod HL - Search Results

1

Current pharmacogenomic studies on hERG potassium channels.

He FZ, McLeod HL, Zhang W. He FZ, et al. Among authors: mcleod hl. Trends Mol Med. 2013 Apr;19(4):227-38. doi: 10.1016/j.molmed.2012.12.006. Epub 2013 Jan 29. Trends Mol Med. 2013. PMID: 23369369 Review.

2

Pharmacogenomic discovery using cell-based models.

Welsh M, Mangravite L, Medina MW, Tantisira K, Zhang W, Huang RS, McLeod H, Dolan ME. Welsh M, et al. Pharmacol Rev. 2009 Dec;61(4):413-29. doi: 10.1124/pr.109.001461. Pharmacol Rev. 2009. PMID: 20038569 Free PMC article. Review.

3

Pharmacogenetics and rational drug use around the world.

Roederer MW, Sanchez-Giron F, Kalideen K, Kudzi W, McLeod HL, Zhang W; Pharmacogenetics for Every Nation Initiative. Roederer MW, et al. Among authors: mcleod hl. Pharmacogenomics. 2011 Jun;12(6):897-905. doi: 10.2217/pgs.11.17. Pharmacogenomics. 2011. PMID: 21692619

4

Epigenetic perspectives on cancer chemotherapy response.

Liu MZ, McLeod HL, He FZ, Chen XP, Zhou HH, Shu Y, Zhang W. Liu MZ, et al. Among authors: mcleod hl. Pharmacogenomics. 2014 Apr;15(5):699-715. doi: 10.2217/pgs.14.41. Pharmacogenomics. 2014. PMID: 24798726 Review.

5

Immunoclassification characterized by CD8 and PD-L1 expression is associated with the clinical outcome of gastric cancer patients.

Wang W, Wang K, Chen Z, Chen L, Guo W, Liao P, Rotroff D, Knepper TC, Liu Z, Zhang W, Mcleod HL, He Y. Wang W, et al. Among authors: mcleod hl. Oncotarget. 2018 Jan 6;9(15):12164-12173. doi: 10.18632/oncotarget.24037. eCollection 2018 Feb 23. Oncotarget. 2018. PMID: 29552300 Free PMC article.

6

Clinical and pharmacogenetics associated with recovery time from general anesthesia.

Xie S, Ma W, Shen M, Guo Q, Wang E, Huang C, Wang Y, Chen X, Liu Z, Zhang W, McLeod HL, He Y. Xie S, et al. Among authors: mcleod hl. Pharmacogenomics. 2018 Sep 1;19(14):1111-1123. doi: 10.2217/pgs-2018-0085. Epub 2018 Aug 23. Pharmacogenomics. 2018. PMID: 30136624

7

Genome-scale analysis identifies SERPINE1 and SPARC as diagnostic and prognostic biomarkers in gastric cancer.

Liao P, Li W, Liu R, Teer JK, Xu B, Zhang W, Li X, Mcleod HL, He Y. Liao P, et al. Among authors: mcleod hl. Onco Targets Ther. 2018 Oct 15;11:6969-6980. doi: 10.2147/OTT.S173934. eCollection 2018. Onco Targets Ther. 2018. PMID: 30410354 Free PMC article.

8

Propranolol Suppresses the Growth of Colorectal Cancer Through Simultaneously Activating Autologous CD8⁺ T Cells and Inhibiting Tumor AKT/MAPK Pathway.

Liao P, Song K, Zhu Z, Liu Z, Zhang W, Li W, Hu J, Hu Q, Chen C, Chen B, McLeod HL, Pei H, Chen L, He Y. Liao P, et al. Among authors: mcleod hl. Clin Pharmacol Ther. 2020 Sep;108(3):606-615. doi: 10.1002/cpt.1894. Epub 2020 Jun 15. Clin Pharmacol Ther. 2020. PMID: 32418204 Clinical Trial.

9

High levels of tumor-infiltrating lymphocytes showed better clinical outcomes in FOLFOX-treated gastric cancer patients.

Li W, Wang W, Liao P, Song K, Zhu Z, Wang K, Liu Z, Zhang W, Xie S, He Y, Mcleod HL, Chen L. Li W, et al. Among authors: mcleod hl. Pharmacogenomics. 2020 Jul;21(11):751-759. doi: 10.2217/pgs-2019-0102. Epub 2020 Jul 3. Pharmacogenomics. 2020. PMID: 32615909

10

Clinical Use of Propranolol Reduces Biomarkers of Proliferation in Gastric Cancer.

Hu Q, Liao P, Li W, Hu J, Chen C, Zhang Y, Wang Y, Chen L, Song K, Liu J, Zhang W, Li Q, McLeod HL, He Y. Hu Q, et al. Among authors: mcleod hl. Front Oncol. 2021 Apr 26;11:628613. doi: 10.3389/fonc.2021.628613. eCollection 2021. Front Oncol. 2021. PMID: 33981600 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters